ORGANIZATION

• Over Half of Companies Control Supply of Off-Label Information: Ihoken Survey
  August 27, 2018

• Regulatory Science Society Says “No” to Off-Label Info Supply by Drug Reps Conditionally OK’ed in Draft MHLW GLs
  August 24, 2018

• Drug Wholesalers Post Virtually Flat Sales in FY2017: JPWA
  August 10, 2018

• Total No. of Sales Reps Shrinks for 4 Years in a Row at 62,433: Survey
  July 27, 2018

• Generic Use Rate at 74.1% in January-March: JGA
  July 4, 2018

• Yokokura Wins 4th Term to Lead Japan Medical Association
  June 25, 2018

• Expand Exemption Criteria in New Off-Patent Price Cut Rule: Japan Pharma Lobby
  June 19, 2018

• Japan Pharma Group Calls for Careful Approach on PMP Deduction for Comparator Drugs
  June 19, 2018

• Don’t Make Coverage Decision on CEA, Tweak Prices with Limited Scope: FPMAJ
  June 18, 2018

• Scrap Unfair Company Criteria for Price Maintenance Premium: Japan Trade Group
  June 18, 2018

• FPMAJ Welcomes Chuikyo’s Openness to Views of Experts on CEA: Drug Pricing Committee Chair
  June 18, 2018

• Atsushi Kamide of Astellas Elected as New Chairman of FPMAJ’s Drug Pricing Committee
  June 18, 2018

• Hiroki Nakatani Named as New Board Chair for GHIT Fund
  June 8, 2018

• JPMA Proposes Creation of Disease Registry to Employ Medical Data
  June 5, 2018

• New JPMA Chief Calls for Scrapping PMP Company Criteria
  June 1, 2018

• Sawai President Elected New Generic Industry Chief
  May 30, 2018

• Drug Damage Watchdog Submits Opinion to Health Ministry, Opposing Current Conditional Early Approval System
  May 30, 2018

• Big Data Analysis Finds Low Generic Drug Use Rate among Healthcare Professionals: Kyokai Kenpo
  May 28, 2018

• Daiichi Sankyo CEO Nakayama Appointed as New President of JPMA
  May 25, 2018

• Isao Teshirogi Elected New FPMAJ Chairman
  May 25, 2018

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »